Hypertension: Difference between revisions
Jump to navigation
Jump to search
imported>Peter A. Lipson |
imported>Matt Mahlmann (added wikilinks, categories) |
||
| Line 1: | Line 1: | ||
'''Hypertension''' is a multisystem disease whose hallmark is the elevation of blood pressure. | '''Hypertension''' is a multisystem [[disease]] whose hallmark is the elevation of [[blood pressure]]. | ||
==Definition== | ==Definition== | ||
| Line 15: | Line 15: | ||
*(Formatting needed)"Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.JAMA. 2002;288:2981-2997. | *(Formatting needed)"Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.JAMA. 2002;288:2981-2997. | ||
[[Category:CZ Live]] | |||
[[Category:Health Sciences Workgroup]] | [[Category:Health Sciences Workgroup]] | ||
Revision as of 20:15, 8 May 2007
Hypertension is a multisystem disease whose hallmark is the elevation of blood pressure.
Definition
Epidemiology
Etiology
Pathophysiology
Diagnosis & Natural History
Treatment
References
- http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf
- (Formatting needed)"Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.JAMA. 2002;288:2981-2997.